ArticleRisk management and healthcare policy2020

Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study.

Giorgio Walter Canonica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.